BROQUERES-YOU D., BEHR-ROUSSEL D., S. OGER S., COMPAGNIE S., CAISEY S., DENYS P., CHARTIER-KASTLER E., GIULIANO F.

Rho-kinase inhibition impacts neurogenic detrusor overactivity in chronic spinalized rats
WorldPharma, Basic & Clinical Pharmacology & Toxicology – 2010 : 107 (Suppl. 1), 192

PHE, S. OGER, D. BEHR-ROUSSEL, P. DENYS, E. COMPERAT, F. GIULIANO, E. CHARTIER-KASTLER.

Spontaneous contractile activity of human neurogenic bladder strips: Can we predict a correlation with between clinical factors, urodynamics and histological features ?
EAU, European Urology Supplements – 2012 : 11; e472

PHE, D. BEHR-ROUSSEL, S. OGER, E. CHARTIER-KASTLER, T. GHONEIM, T. LEBRET, G. KARSENTY, E. COMPERAT, P. CAMPARO, P. VALIDIRE, F. GIULIANO.

Evidence for a functional role of connexin 43 and 45 in human neurogenic detrusor overactivity
EAU, European Urology Supplements – 2012 : 11, e369

BEHR-ROUSSEL, S. OGER-ROUSSEL, B. PIGNOL, E. PHAM, A. LE MAUX, P.E. CHABRIER, P. PICAUT, S. CAISEY, S. COMPAGNIE, F. GIULIANO, P. DENYS.

Minimal effective dose (MED) of onabotulinumtoxinA (onaBoNT-A) and abobotulinumtoxinA (aboBoNT-A) in a rat model of neurogenic detrusor overactivity (NDO)
EAU, European Urology Supplements – 2012 : 11; e462